Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes

Figure 2

Plasma chemerin concentrations in relation to the number of diabetic microvascular complications. As shown, plasma chemerin concentrations elevated significantly with increasing number of microangiopathic complications in diabetes. P-value for significant difference between the groups was determined by the one-way analysis of variance (ANOVA).